Neurology monitoring devices (such as Magnetic Resonance Imaging (MRI) Devices, Intracranial Pressure Monitors, Cerebral Oximeters, Electroencephalography Devices, And Others, are used to monitor and diagnose neurological conditions. The state of the patient's brain activity is monitored through neurology monitoring devices. Thus, with the increase in burden of neurological disorders, the demand for neurology monitoring devices is also increasing rapidly.

Market Dynamics:

Increase in burden of neurological disorders, growing geriatric population, increase in demand for neurology patient monitoring, growing incidence of traumatic brain injuries, and rise in awareness among people is expected to propel growth of the global neurology monitoring market during the forecast period. There is a need for safe and effective devices to diagnose and monitor neurological diseases such as Alzheimer’s disease and Parkinson’s disease, among others.

For instance, in May 2022, NeuraLight raised US$ 25 million to advance its neurology diagnostics tech. NeuraLight planned to work with companies and researchers running clinical trials for novel therapies for neurological diseases such as Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis to help monitor the neurological status of participants. NeuraLight was set up last year and is using computer vision, deep learning, and artificial intelligence (AI) technologies to analyses eye photos taken with a standard webcam or smartphone camera for signs of neurological disease.

Key features of the study:

• This report provides in-depth analysis of the global neurology monitoring market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global neurology monitoring market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Masimo Corporation, Drägerwerk AG & Co. KgaA, Advanced Brain Monitoring Inc., Medtronic plc, Compumedics Limited, Siemens Healthcare GmbH, Koninklijke Philips N.V, Nihon Kohden Corporation, Natus Medical Incorporated, and General Electric Company (GE Healthcare).
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global neurology monitoring market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurology monitoring market.

Detailed Segmentation:

• Global Neurology Monitoring Market, By Product Type:
  • Magnetic Resonance Imaging (MRI) Devices
  • Electroencephalography Devices
  • Cerebral Oximeters
  • Intracranial Pressure Monitors
  • Other Product Types
• Global Neurology Monitoring Market, By Disease Type:
  • Traumatic Brain Injury (TBI)
  • Stroke
  • Sleep Disorders
  • Parkinson's Disease
  • Epilepsy
  • Other Diseases
• Global Neurology Monitoring Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America
• Company Profiles:
  • Masimo Corporation
  • Drägerwerk AG & Co. KgaA
  • Advanced Brain Monitoring Inc.
  • Medtronic plc
  • Compumedics Limited
  • Siemens Healthcare GmbH
  • Koninklijke Philips N.V.
  • Nihon Kohden Corporation
  • Natus Medical Incorporated
  • General Electric Company (GE Healthcare)